Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

1.

Curcumin improves the therapeutic efficacy of Listeria(at)-Mage-b vaccine in correlation with improved T-cell responses in blood of a triple-negative breast cancer model 4T1.

Singh M, Ramos I, Asafu-Adjei D, Quispe-Tintaya W, Chandra D, Jahangir A, Zang X, Aggarwal BB, Gravekamp C.

Cancer Med. 2013 Aug;2(4):571-82. doi: 10.1002/cam4.94. Epub 2013 Jul 2.

2.

Direct incorporation of the NKT-cell activator α-galactosylceramide into a recombinant Listeria monocytogenes improves breast cancer vaccine efficacy.

Singh M, Quispe-Tintaya W, Chandra D, Jahangir A, Venkataswamy MM, Ng TW, Sharma-Kharkwal S, Carreño LJ, Porcelli SA, Gravekamp C.

Br J Cancer. 2014 Nov 11;111(10):1945-54. doi: 10.1038/bjc.2014.486. Epub 2014 Oct 14.

3.

Mage-b vaccine delivered by recombinant Listeria monocytogenes is highly effective against breast cancer metastases.

Kim SH, Castro F, Gonzalez D, Maciag PC, Paterson Y, Gravekamp C.

Br J Cancer. 2008 Sep 2;99(5):741-9. doi: 10.1038/sj.bjc.6604526. Epub 2008 Aug 19.

4.

STING ligand c-di-GMP improves cancer vaccination against metastatic breast cancer.

Chandra D, Quispe-Tintaya W, Jahangir A, Asafu-Adjei D, Ramos I, Sintim HO, Zhou J, Hayakawa Y, Karaolis DK, Gravekamp C.

Cancer Immunol Res. 2014 Sep;2(9):901-10. doi: 10.1158/2326-6066.CIR-13-0123. Epub 2014 Jun 9.

5.

High efficacy of a Listeria-based vaccine against metastatic breast cancer reveals a dual mode of action.

Kim SH, Castro F, Paterson Y, Gravekamp C.

Cancer Res. 2009 Jul 15;69(14):5860-6. doi: 10.1158/0008-5472.CAN-08-4855. Epub 2009 Jul 7.

6.

Myeloid-derived suppressor cells have a central role in attenuated Listeria monocytogenes-based immunotherapy against metastatic breast cancer in young and old mice.

Chandra D, Jahangir A, Quispe-Tintaya W, Einstein MH, Gravekamp C.

Br J Cancer. 2013 Jun 11;108(11):2281-90. doi: 10.1038/bjc.2013.206. Epub 2013 May 2.

7.

In vivo responses to vaccination with Mage-b, GM-CSF and thioglycollate in a highly metastatic mouse breast tumor model, 4T1.

Gravekamp C, Leal B, Denny A, Bahar R, Lampkin S, Castro F, Kim SH, Moore D, Reddick R.

Cancer Immunol Immunother. 2008 Jul;57(7):1067-77.

PMID:
18094967
8.

Vaccination with Mage-b DNA induces CD8 T-cell responses at young but not old age in mice with metastatic breast cancer.

Castro F, Leal B, Denny A, Bahar R, Lampkin S, Reddick R, Lu S, Gravekamp C.

Br J Cancer. 2009 Oct 20;101(8):1329-37. doi: 10.1038/sj.bjc.6605329. Epub 2009 Sep 29.

9.

Prevention of metastases with a Mage-b DNA vaccine in a mouse breast tumor model: potential for breast cancer therapy.

Sypniewska RK, Hoflack L, Tarango M, Gauntt S, Leal BZ, Reddick RL, Gravekamp C.

Breast Cancer Res Treat. 2005 May;91(1):19-28.

PMID:
15868428
11.

Cryoablation and Meriva have strong therapeutic effect on triple-negative breast cancer.

Chandra D, Jahangir A, Cornelis F, Rombauts K, Meheus L, Jorcyk CL, Gravekamp C.

Oncoimmunology. 2015 May 29;5(1):e1049802. eCollection 2016.

12.
13.
16.

Prophylactic and therapeutic efficacy of an attenuated Listeria monocytogenes-based vaccine delivering HPV16 E7 in a mouse model.

Jia Y, Yin Y, Duan F, Fu H, Hu M, Gao Y, Pan Z, Jiao X.

Int J Mol Med. 2012 Dec;30(6):1335-42. doi: 10.3892/ijmm.2012.1136. Epub 2012 Sep 20.

PMID:
23027427
17.

Myeloid suppressor cell depletion augments antitumor activity in lung cancer.

Srivastava MK, Zhu L, Harris-White M, Kar UK, Huang M, Johnson MF, Lee JM, Elashoff D, Strieter R, Dubinett S, Sharma S.

PLoS One. 2012;7(7):e40677. doi: 10.1371/journal.pone.0040677. Epub 2012 Jul 16. Erratum in: PLoS One. 2012;7(10). doi:10.1371/annotation/5c756e7d-6e97-416f-836a-dced97cf46af. Kar, Upendra [corrected to Kar, Upendra K].

18.
19.

Development of a Listeria monocytogenes-based vaccine against hepatocellular carcinoma.

Chen Y, Yang D, Li S, Gao Y, Jiang R, Deng L, Frankel FR, Sun B.

Oncogene. 2012 Apr 26;31(17):2140-52. doi: 10.1038/onc.2011.395. Epub 2011 Sep 19. Erratum in: Oncogene. 2012 Nov 8;31(45):4810.

PMID:
21927025

Supplemental Content

Support Center